Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption

Bosentan is an endothelin receptor antagonist (ERA) prescribed for patients with pulmonary arterial hypertension (PAH). The oral delivery of bosentan possesses several drawbacks such as low bioavailability (about 50%), short duration of action, frequent administration, hepatotoxicity and systemic hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Lydia A., Basalious, Emad B., ELGazayerly, Omaima N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241195/
https://www.ncbi.nlm.nih.gov/pubmed/28156176
http://dx.doi.org/10.1080/10717544.2016.1239661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241195/
https://www.ncbi.nlm.nih.gov/pubmed/28156176
http://dx.doi.org/10.1080/10717544.2016.1239661

Ejemplares similares